Debio 1453

N. gonorrhoeae

Debio 1453 is a FabI inhibitor specifically targeting N. gonorrhoeae developed in collaboration with Nobelex. This compound belongs to a family of narrow-spectrum antiobiotics that combines a very potent activity on pathogens of interest while reducing the selective pressure on other bacterial strains and sparing the microbiome.

Press Releases

All Press Releases